These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32737615)

  • 1. The Effects of Dose Volume and Excipient Dose on Luminal Concentration and Oral Drug Absorption.
    Aungst BJ
    AAPS J; 2020 Jul; 22(5):99. PubMed ID: 32737615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics.
    Pade D; Jamei M; Turner DB; Mistry B; Martinez MN
    Eur J Pharm Biopharm; 2019 Aug; 141():191-209. PubMed ID: 31150808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of signal interference from dosing excipients on pharmacokinetic screening of drug candidates by liquid chromatography/mass spectrometry.
    Tong XS; Wang J; Zheng S; Pivnichny JV; Griffin PR; Shen X; Donnelly M; Vakerich K; Nunes C; Fenyk-Melody J
    Anal Chem; 2002 Dec; 74(24):6305-13. PubMed ID: 12510753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of sorbitol as pharmaceutical excipient in the present day formulations - issues and challenges for drug absorption and bioavailability.
    Dash RP; Srinivas NR; Babu RJ
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1421-1429. PubMed ID: 31271324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of excipients on oral absorption process according to the different gastrointestinal segments.
    Ruiz-Picazo A; Lozoya-Agullo I; González-Álvarez I; Bermejo M; González-Álvarez M
    Expert Opin Drug Deliv; 2021 Aug; 18(8):1005-1024. PubMed ID: 32842776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update.
    Zhang W; Li Y; Zou P; Wu M; Zhang Z; Zhang T
    AAPS J; 2016 Jul; 18(4):830-43. PubMed ID: 27184579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a statistical method to the absorption of a new model drug from micellar and lipid formulations--evaluation of qualitative excipient effects.
    Kuentz M; Wyttenbach N; Kuhlmann O
    Pharm Dev Technol; 2007; 12(3):275-83. PubMed ID: 17613891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of presence of excipients in drug analysis in fed-state gastric biorelevant media.
    Baxevanis F; Kuiper J; Fotaki N
    Eur J Pharm Biopharm; 2018 Oct; 131():178-188. PubMed ID: 30110669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Absorption Behavior of Solubilizers on Drug Dissolution in the Gastrointestinal Tract: Evaluation Based on In Vivo Luminal Concentration-Time Profile of Cilostazol, a Poorly Soluble Drug, and Solubilizers.
    Tanaka Y; Kubota A; Matsuo A; Kawakami A; Kamizi H; Mochigoe A; Hiramachi T; Kasaoka S; Yoshikawa H; Nagata S
    J Pharm Sci; 2016 Sep; 105(9):2825-2831. PubMed ID: 27025982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Luminal Fluid Volume on the Drug Absorption After Oral Administration: Analysis Based on In Vivo Drug Concentration-Time Profile in the Gastrointestinal Tract.
    Tanaka Y; Goto T; Kataoka M; Sakuma S; Yamashita S
    J Pharm Sci; 2015 Sep; 104(9):3120-7. PubMed ID: 25821198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
    Linn M; Collnot EM; Djuric D; Hempel K; Fabian E; Kolter K; Lehr CM
    Eur J Pharm Sci; 2012 Feb; 45(3):336-43. PubMed ID: 22172603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations.
    Williams HD; Ford L; Han S; Tangso KJ; Lim S; Shackleford DM; Vodak DT; Benameur H; Pouton CW; Scammells PJ; Porter CJH
    Mol Pharm; 2018 Dec; 15(12):5678-5696. PubMed ID: 30376336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study-Hypromellose (HPMC).
    Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
    AAPS J; 2020 Feb; 22(2):49. PubMed ID: 32072317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile and excipient interactions directing drug pharmacokinetics in rats.
    Schlauersbach J; Hanio S; Raschig M; Lenz B; Scherf-Clavel O; Meinel L
    Eur J Pharm Biopharm; 2022 Sep; 178():65-68. PubMed ID: 35932963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An animal's sex influences the effects of the excipient PEG 400 on the intestinal P-gp protein and mRNA levels, which has implications for oral drug absorption.
    Mai Y; Dou L; Murdan S; Basit AW
    Eur J Pharm Sci; 2018 Jul; 120():53-60. PubMed ID: 29678614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal Drug Absorption from Powder Formulations: Effect of Fluid Volume Changes on the Mucosal Surface.
    Tanaka A; Furubayashi T; Enomura Y; Hori T; Shimomura R; Maeda C; Kimura S; Inoue D; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Biol Pharm Bull; 2017; 40(2):212-219. PubMed ID: 28154262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cyclodextrins and drugs after oral and parenteral administration of drug/cyclodextrin complexes.
    Loftsson T; Moya-Ortega MD; Alvarez-Lorenzo C; Concheiro A
    J Pharm Pharmacol; 2016 May; 68(5):544-55. PubMed ID: 26059798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.